Angiogenesis - Part I. Mechanism of neovascularization;Angiogeneza - Czȩść I. Mechanizm polwstawania nowych naczyń krwionośnych

Alergia Astma Immunologia

Volumn 8, Issue 4, 2003, Pages 169-174

  Zielonka, Tadeusz M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Angiogenesis; bFGF; Immunology; Pathogenesis; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; INTEGRIN; METALLOPROTEINASE; VASCULOTROPIN;

ANGIOGENESIS; BASEMENT MEMBRANE; CANCER; CELL PROLIFERATION; CELL STIMULATION; CHRONIC INFLAMMATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEREDITY; HUMAN; HYPOXIA; IMMUNOLOGY; ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PERICYTE; REVIEW; SMOOTH MUSCLE;

EID: 1542318934     PISSN: 14273101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674.
2. Risau W, Flamme I. Vasculogenesis. Ann Rev Cell Dev Biol 1995; 11: 73-91.
3. Breier G. Angiogenesis in embryonic development - a review. Placenta 2000; 21 (Suppl. 14): S11-S15.
4. Hazzard TM, Stouffer RL. Angiogenesis in ovarian follicular and luteal development. Bailliere's Clin Obstet Gynecol 2000; 14: 883-900.
5. Smith S. Angiogenesis and implantation. Hum Reprod 2000; 15(Suppl.6): 59-66.
6. Hansen-Smith FM, Morris L. Patterns of physiological angiogenesis in adult mesentery. w: Angiogenesis: Models, Modulators, and Clinical Applications. (wyd.) ME Maragoudakis Plenum Press, NY 1998; 75-84.
7. Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am 1997; 77: 509-528.
8. Lingen M. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 2001; 125: 67-71.
9. Folkman J. Addressing tumor blood vessels. Nature Biotechn 1997; 15: 510-511.
10. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogenes 1999; 18: 5356-5362.
11. Nacov E. Tumor angiogenesis formation of vessels de noyo at germ cell tumors. Cancer 1990; 66: 916-922.
12. Folkman J. Angiogenesis and angiogenesis inhibition. EXS 1997; 79: 1-8.
13. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
14. Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1999; 40: 2453-2457.
15. Bouloumié A, Drexler H, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998; 83: 1059-1066.
16. Rabinovitch M. Pulmonary hypertension: patophysiology as a basis for clinical decision making. J Heart Lung Transpl 1999; 18: 1041-1053.
17. Banai S, Shweiki D, Pinson A i wsp. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc Res 1994; 28: 1176-1179.
18. Manoonkitiwongsa PS, Jackson-Friedman C, McMillan PJ i wsp. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J Cereb Blood Flow Metab 2001; 21: 1223-1231.
19. Rajotte D, Arap W, Hagedron M, Koivunen E, Pasqualini R, Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 1998; 102; 430-437.
20. Browder T, Folkman J, Pirie-Shephard S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 2000; 275: 1521-1524.
21. 165- induced angiogenesis. APMIS 2000; 108: 29-37.
22. Ferrara N. Role of vascular endothelial growth factor in regulation of angiogenesis. Kidney Int 1999; 56: 794-814.
23. Senger DR, Galli SJ, Dvorak AM i wsp. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash DC) 1983; 219: 983-985.
24. Ziche M, Morbidelli L, Choudhuri R i wsp. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-2634.
25. Ferrara N, Keyt B. Vascular endothelial growth factor: Basic biology and clinical implication. EXS 1997; 79: 209-232.
26. Gupta K, Kshirsagar S, Li W i wsp. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 1999; 247: 495-504.
27. Brown L, Detmar M, Claffey K i wsp. Vascular permeability factor/ vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS 1997; 79: 33-69.
28. Forsythe JA, Jiang BH, Iyer NV i wsp. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613.
29. Carmeliet P. Role of HIF-1a hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 94: 485-490.
30. Hansen-Algenstaedt N, Fukumura D, Stoll B, Hicklin D, Jain RK. Second wave of angiogenesis during KDR/Flk-1 antibody therapy. Proc Am Assoc Canc Res 1999; 40: 620-620.
31. Hiraoka N, Allen E, Apel I, Gyetko MR, Weiss SJ. Matrix metalloproteinase regulate neovasularization by acting as pericellular fibrinolysins. Cell 1998; 95: 365-377.
32. Gleizes PE, Noaillac-Depeyre J, Amalric F, Gas N. Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglicans-mediated pathway: An ultrastructural approach. Eur J Cell Biol 1995; 66: 47-59.
33. Klein S, Roghani M, Rifkin DB. Fibroblast growth factors as angiogenesis factors: New insights into their mechanism of action. EXS 1997; 79: 159-192.
34. v integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103: 1227-1230.
35. Howe A, Aplin AE, Alaharie SK, Juliano RL. Integrin signaling and cell growth control. Curr Opin Cell Biol 1998; 10: 220-231.
36. Strömblad S, Cheresh DA. Integrins, angiogenesis and vascular cell survival. Chem Biol 1996; 3: 8818-85.
37. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct Alpha v integrins. Science (Wash DC) 1995; 270: 1500-1502.
38. diPietro LA. Thrombospondin as a regulator of agiogenesis. EXS 1997; 79: 295-314.
39. Grant DS, Kleinman HK. Regulation of capillary formation by laminin and other components of the extracellular matrix. EXS 1997; 79: 317-333.
40. Sato TN, Beitz JG, Kato J i wsp. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993; 142: 1119-1130.
41. Hirschi KK, D'Amore PA. Control of angiogenesis by the pericyte: Molecular mechanisms and significance. EXS 1997; 79: 419-428.
42. Kanda S, Landgren E, Ljungstrom M, Claesson Welsh L. Fibroblast growth factor receptor 1-induced differentiation of endothelial cell line established from TsA large T transgenic mice. Cell Growth Differ 1996; 7: 383-395.
43. Maisonpierre PC, Suri C, Jones PF i wsp. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (Wash DC) 1997; 277: 55-60.
44. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 1995; 14: 5884-5891.
45. Sato TN, Tozawa Y, Deutsch U i wsp. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie2 in blood vessel formation. Nature (Lond) 1995; 376: 70-74.
46. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 1997; 81: 567-574.
47. Asahara T, Masuda H, Takahashi T i wsp. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnatal neovascularization. Circ Res 1998; 83: 233-240.
48. Korpelainen EI, Alitalo K. Signaling angiogenesis and lymphangiogenesis. Curr Opin Cell Biol 1998; 10: 159-164.
49. Vikkula M, Boon L, Mulliken JB, Olsen BR. Molecular basis of vascular anomalies. Trends Cardiovasc. Med. 1998; 8: 281-292.
50. Blair RJ, Meng H, Marchese MJ i wsp. Human mast cells stimulate vascular tube formation. Tryptase is a novel potent angiogenic factor. J Clin Invest 1997; 99: 2691-2700.
51. Sunderkotter C, Steinbrink K, Henseleit U i wsp. Activated T cells induce expression of E-selectin in vitro and in an antigen dependent manner in vivo. Eur J Immunol 1996; 26: 1571-1579.
52. Mach F, Schonbeck U, Fabunmi RP i wsp. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism - Implications for tubule formation. Am J Pathol 1999; 154: 229-238.
53. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenic. Adv Cancer Res 1996; 69: 135-174.
54. Pepper MS, Mandriota SJ, Vassalli J-D, Orci L, Montesano R. Angiogenesis-regulating cytokines: activities and interactions. Curr. Topics Microbiol Immun 1996; 213: 31-67.
55. Yoshida S, Ono M, Shono T i wsp. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis α-dependent angiogenesis. Mol Cell Biol 1997; 17: 4015-4023.
56. Giraudo E, Primo L, Audero E i wsp. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem 1998; 273: 22128-22135.
57. Schiffenbauer YS, Abramovitch R, Meir G. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 1997; 94: 13203-13208.
58. Okada F, Rak JW, Croix BS i wsp. Impact of oncogenesis in tumor angiogenesis: Mutant K-Ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci USA 1998; 95: 3609-3614.